Introduction Metformin is a first line oral medication for diabetes mellitus shown to decrease cardiovascular morbidity and mortality. Though the prevalence of metformin-associated lactic acidosis (MALA) is low, mortality is high, ranging from 25-50%. Therefore, it presents a diagnostic challenge that is critical to identify, particularly in patients with renal impairment at baseline. Traditionally patients with creatinine greater than 1.5 mg/dL have been excluded from using metformin; however, metformin might be acceptable in some patients with chronic kidney disease (CKD). Case Presentation: A 69 year old female with a past medical history of diabetes mellitus, hypertension, breast cancer, and no chronic kidney disease was sent to the hos...
Introduction Use of metformin increases plasma lactate concentration and may lead to metformin-assoc...
Metformin is recommended as a first-line treatment for patients with diabetes mellitus type 2; it ha...
Lactic acidosis (LA) secondary to metformin administration is a rare incident with a very highmortal...
Metformin induced lactic acidosis is when high levels of metformin cause dangerously high levels of ...
Metformin intoxication with lactic acidosis, a potentially lethal condition, may develop in diabetic...
Metformin is widely used to treat type 2 diabetes mellitus. Some patients with renal dysfunction can...
Metformin (MF) accumulation during acute kidney injury is associated with high anion gap lactic acid...
BACKGROUND: Lactic acidosis in metformin use is a widely recognised but rare side effect. Case repor...
Metformin is a commonly used treatment modality in type 2 diabetes mellitus with lactic acidosis as ...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
Metformin-associated lactic acidosis [MALA] is a potentially fatal condition characterized by an ele...
INTRODUCTION: Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patient...
peer-reviewedMetformin is considered the first line oral hypoglycaemic agent for the treatment of ty...
Background: Metformin associated lactic acidosis (MALA) is a well-known serious side effect of bigua...
Metformin is a safe drug when correctly used in properly selected patients. In real life, however, a...
Introduction Use of metformin increases plasma lactate concentration and may lead to metformin-assoc...
Metformin is recommended as a first-line treatment for patients with diabetes mellitus type 2; it ha...
Lactic acidosis (LA) secondary to metformin administration is a rare incident with a very highmortal...
Metformin induced lactic acidosis is when high levels of metformin cause dangerously high levels of ...
Metformin intoxication with lactic acidosis, a potentially lethal condition, may develop in diabetic...
Metformin is widely used to treat type 2 diabetes mellitus. Some patients with renal dysfunction can...
Metformin (MF) accumulation during acute kidney injury is associated with high anion gap lactic acid...
BACKGROUND: Lactic acidosis in metformin use is a widely recognised but rare side effect. Case repor...
Metformin is a commonly used treatment modality in type 2 diabetes mellitus with lactic acidosis as ...
Metformin, a biguanide, is widely accepted to be the preferred first-line oral antihyperglycaemic ag...
Metformin-associated lactic acidosis [MALA] is a potentially fatal condition characterized by an ele...
INTRODUCTION: Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patient...
peer-reviewedMetformin is considered the first line oral hypoglycaemic agent for the treatment of ty...
Background: Metformin associated lactic acidosis (MALA) is a well-known serious side effect of bigua...
Metformin is a safe drug when correctly used in properly selected patients. In real life, however, a...
Introduction Use of metformin increases plasma lactate concentration and may lead to metformin-assoc...
Metformin is recommended as a first-line treatment for patients with diabetes mellitus type 2; it ha...
Lactic acidosis (LA) secondary to metformin administration is a rare incident with a very highmortal...